share_log

Investors Three-year Losses Continue as Asymchem Laboratories (Tianjin) (SZSE:002821) Dips a Further 4.3% This Week, Earnings Continue to Decline

Investors Three-year Losses Continue as Asymchem Laboratories (Tianjin) (SZSE:002821) Dips a Further 4.3% This Week, Earnings Continue to Decline

投資者三年損失持續,凱萊英(天津)(SZSE:002821)本週再下跌4.3%,收益繼續下降
Simply Wall St ·  12/15 08:12

While not a mind-blowing move, it is good to see that the Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) share price has gained 27% in the last three months. But that is meagre solace in the face of the shocking decline over three years. The share price has sunk like a leaky ship, down 74% in that time. So it sure is nice to see a bit of an improvement. Of course the real question is whether the business can sustain a turnaround.

雖然這不是一個震撼的舉動,但看到凱萊英(臨時代碼)的股價在過去三個月中上漲了27%還是不錯的。但是,在面對三年來的驚人下跌時,這只是微不足道的安慰。在此期間,股價像漏水的船一樣下沉,下降了74%。因此,看到一些改善確實令人高興。當然真正的問題是,業務是否能夠維持好轉。

After losing 4.3% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

在過去一週下跌4.3%之後,值得調查公司的基本面,以看看我們可以從過去的表現中推斷出什麼。

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

借用本傑明·格雷厄姆的話來說:短期內市場是一個投票機,但長期來說它是一個稱重機。一種存在缺陷但合理的評估公司情緒變化的方法是將每股收益(EPS)與股價進行比較。

Asymchem Laboratories (Tianjin) saw its EPS decline at a compound rate of 7.0% per year, over the last three years. This reduction in EPS is slower than the 36% annual reduction in the share price. So it seems the market was too confident about the business, in the past.

凱萊英(臨時代碼)的每股收益在過去三年中以每年7.0%的複合率下降。這一每股收益的減少速度慢於股價每年36%的下降幅度。因此,似乎市場過去對業務過於自信。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

您可以在下面看到EPS如何隨時間變化(點擊圖片可以發現具體數值)。

big
SZSE:002821 Earnings Per Share Growth December 15th 2024
深交所:002821 每股收益增長 2024年12月15日

It's good to see that there was some significant insider buying in the last three months. That's a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

很高興看到近三個月內有一些重要的內部買入。這是一個積極的信號。但是,我們認爲盈利和營收增長趨勢更重要。在買入或賣出股票之前,我們總是建議仔細研究歷史增長趨勢,可以在這裏獲得相關數據。

A Different Perspective

不同的視角

While the broader market gained around 13% in the last year, Asymchem Laboratories (Tianjin) shareholders lost 31% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 1.5% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Asymchem Laboratories (Tianjin) you should know about.

儘管在過去一年中,整體市場上漲了約13%,但凱萊英(天津)的股東卻損失了31%(即使包括分紅派息)。然而,請記住,即使是最好的股票,有時也會在一年期內表現不佳。不幸的是,去年的表現可能表明仍然存在未解決的挑戰,因爲它比過去五年的年化損失1.5%還要糟糕。一般來說,長期股價走弱可能是一個壞兆頭,儘管逆向投資者可能會想要研究這隻股票,希望出現反轉。考慮市場狀況對股價的不同影響是非常值得的,但還有其他因素更爲重要。考慮風險,例如。每家公司都存在風險,我們發現了凱萊英(天津)的2個預警信號,這些是你需要了解的。

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar).

如果你喜歡與管理層一起買入股票,那麼你可能會喜歡這份免費的公司名單。(提示:它們中的大多數都在雷達下飛行)。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文中引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論